Legacy Pharmaceutical Packaging LLC is recalling over 5.8 million bottles of Losartan Potassium Tablets (25 mg, 50 mg, and 100 mg) sold under the Camber Pharmaceuticals brand at Wal-Mart. The recall was initiated because testing detected the presence of N-Methylnitrosobutyric acid (NMBA), an impurity that does not meet safety standards for drug manufacturing. These prescription blood pressure medications were distributed to Wal-Mart distribution centers in Arkansas, California, Georgia, Indiana, and Maryland.
The tablets contain NMBA, which is a known environmental impurity and a potential human carcinogen. Long-term exposure to levels above acceptable limits may increase the risk of cancer.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.